Stock Rich List
#13563 on the rich list of 14,644 insiders

Patrick G. Enright

Director at Veradermics; Director at Vera Therapeutics; Director at Zenas BioPharma. Based in Menlo Park, California.

$5.5M
in disclosed stock, −$251K (−4.37%) today
Market closed. Prices as of Nov 19, 4:00 PM ET
Rank
13563rd of 14,644
Companies held
3
Largest holding
JAZZ, 91.7% of total
Latest SEC filing
Nov 11, 2026
Listed but not counted
$734M

What the $5.5M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Jazz Pharmaceuticals JAZZ
Ordinary Shares
Directly21,278$236.45$5.0M91.7%Form 4, Aug 31, 2026
Zenas BioPharma ZBIO
Common Stock
Directly11,990$25.04$300K5.5%Form 4, Oct 9, 2025
Vera Therapeutics VERA
Class A Common Stock
Directly5,882$26.75$157K2.9%Form 4, Dec 11, 2025

Share counts are the amounts Patrick G. Enright reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Patrick G. Enright's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Veradermics MANE
Common Stock
Through Longitude Venture Partners V, L.P.
Held by a company or fund the insider manages
2,350,399$124.38$292M—Form 4, Nov 11, 2026
Veradermics MANE
Common Stock
Through Longitude 103.8 East, L.P.
Held by a company or fund the insider manages
1,803,474$124.38$224M—Form 4, Nov 11, 2026
Vera Therapeutics VERA
Class A Common Stock
Indirectly (see filing footnote)
Held by a company or fund the insider manages
3,596,593$26.75$96.2M—Form 4, Dec 11, 2025
Vera Therapeutics VERA
Class A Common Stock
Through Longitude Prime Fund, L.P.
Held by a company or fund the insider manages
1,797,619$26.75$48.1M—Form 4, Dec 11, 2025
Zenas BioPharma ZBIO
Common Stock
Through LVPIV. Longitude Capital Partners IV, LLC
Held by a company or fund the insider manages
1,832,669$25.04$45.9M—Form 4, Oct 9, 2025
Zenas BioPharma ZBIO
Common Stock
Through Longitude Prime Fund, L.P.
Held by a company or fund the insider manages
774,530$25.04$19.4M—Form 4, Oct 9, 2025
BioAge Labs BIOA
Common Stock
Longitude Venture Partners IV, L.P.
Held by a company or fund the insider manages
1,710,589$4.71$8.1M—Form 4, Sep 27, 2024

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 11, 2026SoldMANE250,000$150.38$37.6MView
Nov 11, 2026SoldMANE250,000$150.38$37.6MView
Feb 5, 2026BoughtMANE882,353$17.00$15.0MView
Feb 5, 2026BoughtMANE192,647$17.00$3.3MView
Dec 11, 2025BoughtVERA5,882$42.50$250KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
13560Lisa A. Grow
President & CEO, IDACORP. Camden, NJ
$5.5M−$60K (−1.08%)
13561Kurt M. Eckert
Director, Miami International Holdings. Princeton, NJ
$5.5M−$49K (−0.89%)
13562Adam M. Vela
SVP & GENERAL COUNSEL, Devon Energy. Houston, TX
$5.5M+$12K (+0.21%)
13563Patrick G. Enright
Director, Veradermics. Menlo Park, CA
$5.5M−$251K (−4.37%)
13564Simon Jonathan Allen
Director, McGraw Hill. Columbus, OH
$5.5M+$6K (+0.11%)
13565W. Howard Morris
Director, Owens Corning. Hartford, CT
$5.5M−$155K (−2.75%)
13566Rodney C. Adkins
Director, Avnet. Phoenix, AZ
$5.5M−$140K (−2.49%)

Other Veradermics insiders

All MANE insiders

Questions

How much stock does Patrick G. Enright own?

Patrick G. Enright holds $5,488,756 in listed stock based on SEC filings and current prices, mostly Jazz Pharmaceuticals (JAZZ). That ranks 13563rd on the Stock Rich List.

Is this Patrick G. Enright's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Patrick G. Enright last buy or sell stock?

The most recent open-market trade on file is a sale of 250,000 MANE shares on Nov 11, 2026 at $150.38.